640714-45-0Relevant articles and documents
Identification of arylsulfonamides as ExoU inhibitors
Kim, Doran,Baek, Jihae,Song, Jiho,Byeon, Hyeyoung,Min, Hyeyoung,Min, Kyung Hoon
supporting information, p. 3823 - 3825 (2014/09/03)
ExoU is a potent virulence factor of Pseudomonas aeruginosa and is considered a potential therapeutic target. In order to discover novel ExoU inhibitors, we screened an in-house chemical library utilizing a yeast-based screening system. Some sulfonamides displayed significant activity without nonspecific cytotoxicity. We describe a series of sulfonamides as novel ExoU inhibitors, along with a brief structure-activity relationship.
Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120)
Sparks, Steven M.,Chen, Grace,Collins, Jon L.,Danger, Dana,Dock, Steven T.,Jayawickreme, Channa,Jenkinson, Stephen,Laudeman, Christopher,Leesnitzer, M. Anthony,Liang, Xi,Maloney, Patrick,McCoy, David C.,Moncol, David,Rash, Vincent,Rimele, Thomas,Vulimiri, Padmaja,Way, James M.,Ross, Sean
, p. 3100 - 3103 (2015/02/05)
The exploration of a diarylsulfonamide series of free fatty acid receptor 4 (FFA4/GPR120) agonists is described. This work led to the identification of selective FFA4 agonist 8 (GSK137647A) and selective FFA4 antagonist 39. The in vitro profile of compounds 8 and 39 is presented herein.